InsidersTradesSigma
Track the 루닛 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 루닛 has published 99 insider filings. Market capitalisation: €737.1bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: KENNETH GABRIEL NESMITH. All data is free.
99
Insider Decl.
n/a
Thresholds
€2m
18 ops.
Buy Volume
n/a
29 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,145 of 29,062 companies
28.4
score / 100
Value19
Quality38
FCF yld-8.3%
Earn yld-6.0%
EV/EBITDA·
ROE-24%
Gross mgn100%
Net mgn-57%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations99 total
ShareKRXDART:20260223003263
ShareKRXDART:20260223003214
ShareKRXDART:20260116000305
20,000 sharesShareKRXDART:20250407003681
10,000 sharesShareKRXDART:20250124000784
25 of 99 declarations
Acerca de 루닛
루닛 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones de inteligencia artificial para diagnósticos médicos.